[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342606-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342606-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","lncrna-pcat6-is-a-predictor-of-poor-prognosis-of-colorectal-cancer-research-study-summary","LncRNA PCAT6 is a predictor of poor prognosis of colorectal cancer - Research Study Summary","","This study analyzes The Cancer Genome Atlas (TCGA) data to clarify how the long non-coding RNA PCAT6 relates to colorectal cancer (CRC). Wilcoxon rank-sum and logistic regression compare PCAT6 levels with clinicopathological features, while Kaplan-Meier and Cox models evaluate associations with patient survival. Results show higher PCAT6 expression correlates with lymph node metastasis, distant metastasis, CEA level, and more advanced disease, and links to worse overall survival. GSEA implicates PCAT6 in DNA methylation changes and RNA-mediated gene silencing pathways.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/lncrna-pcat6-is-a-predictor-of-poor-prognosis-of-colorectal-cancer-research-study-summary/342606/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/lncrna-pcat6-is-a-predictor-of-poor-prognosis-of-colorectal-cancer-research-study-summary/342606.png","ImageObject",300,407,{"name":42,"@type":43},"Finn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How did the study measure PCAT6 and relate it to CRC?","Question",{"text":63,"@type":64},"PCAT6 expression in CRC tumors and normal tissues was assessed using TCGA-based analyses with Wilcoxon rank-sum tests and logistic regression. Survival associations were evaluated using Kaplan-Meier curves and Cox regression, with CRC cell line expression supported by qRT-PCR.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which clinical features were associated with higher PCAT6 levels?",{"text":68,"@type":64},"Higher PCAT6 levels were significantly associated with CRC lymph node metastasis (N stage), distant metastasis (M stage), higher CEA levels, lymphatic invasion, perineural invasion, and more advanced pathologic stage, including stage III/IV versus I/II.",{"name":70,"@type":61,"acceptedAnswer":71},"What survival impact did PCAT6 expression show?",{"text":72,"@type":64},"CRC patients with higher PCAT6 expression had poorer survival outcomes (P=0.017). The association remained significant in both univariate and multivariate analyses, indicating PCAT6 as a prognostic indicator.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342606,1790137015,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","LncRNA PCAT6 is a predictor of poor prognosis of colorectal cancer  \nLin Han1, Zhuang Li2, Peng Zhang2, Minghui Sheng1, Wenfei Wang1, Yanjun Sun1, Dengqun Sun1  \n1Department of General Surgery, The Armed Police Corps Hospital of Anhui, Hefei, China; 2Graduate School, Anhui University of Chinese Medicine, Hefei, China  \nContributions: (I) Conception and design: L Han, D Sun, Y Sun; (II) Administrative support: D Sun, L Han; (III) Provision of study materials or patients: L Han, M Sheng, W Wang, P Zhang, Z Li; (IV) Collection and assembly of data: L Han, M Sheng, W Wang, P Zhang, Z Li; (V) Data analysis and interpretation: L Han, Y Sun; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \nCorrespondence to: Dengqun Sun, MD, PhD. Department of General Surgery, The Armed Police Corps Hospital of Anhui, No. 8, Changfeng Road, Hefei 230041, China. Email: [sundengqunsyl@126.com](sundengqunsyl@126.com).  \nBackground: The long non-coding RNA (lncRNA) prostate cancer-associated transcript 6 (PCAT6) has been studied in many cancers, yet its relationship with colorectal cancer (CRC) remains poorly defined.  \nHere, we conducted an analysis of The Cancer Genome Atlas (TCGA) database to better clarify the role of  \nPCAT6 in this cancer type.  \nMethods: Wilcoxon rank-sum tests were utilized to assess relative levels of PCAT6 in CRC tumors and normal tissues, while logistic regression analyses were utilized to compare the relationships between PCAT6 levels and clinicopathological findings. Kaplan-Meier curves and Cox regression analyses were used to gauge correlations between PCAT6 and patient survival outcomes, while the biological roles of this lncRNA were investigated via a gene set enrichment analysis (GSEA) approach. The expression level of PCAT6 in CRC  \ncell lines was detected by quantitative reverse transcription polymerase chain reaction (qRT-PCR) .  \nResults: PCAT6 levels were significantly correlated with CRC patient lymph node metastasis (N) stage [odds ratio (OR) =1.8 for N1 & N2 vs. N0], lymphatic invasion [[OR =1.9 for yes](OR =1.9 for yes vs. no)[ vs.](OR =1.9 for yes vs. no)[ no](OR =1.9 for yes vs. no)), distant metastasis (M stage) (OR =2.1 for M1 vs. M0), carcinoembryonic antigen (CEA) level (OR =1.9 for >5 vs. ≤5), perineural invasion ([OR =1.9 for yes](OR =1.9 for yes vs. no), pathologic stage (OR =1.9 for stage III/IV vs. stage I/II), and neoplasm type)[ vs.](OR =1.9 for yes vs. no), pathologic stage (OR =1.9 for stage III/IV vs. stage I/II), and neoplasm type)[ no), pathologic stage (OR =1.9 for stage III/IV](OR =1.9 for yes vs. no), pathologic stage (OR =1.9 for stage III/IV vs. stage I/II), and neoplasm type)[ vs.](OR =1.9 for yes vs. no), pathologic stage (OR =1.9 for stage III/IV vs. stage I/II), and neoplasm type)[ stage I/II), and neoplasm type](OR =1.9 for yes vs. no), pathologic stage (OR =1.9 for stage III/IV vs. stage I/II), and neoplasm type)[ ](OR =1.9 for yes vs. no), pathologic stage (OR =1.9 for stage III/IV vs. stage I/II), and neoplasm type)(OR =2.1 for rectal adenocarcinoma vs. colon adenocarcinoma) (all P\u003C0.05) . CRC patients expressing higher PCAT6 levels exhibited poorer survival outcomes than those expressing low levels of this lncRNA (P=0.017), and in univariate analyses, higher PCAT6 levels were linked to worse overall survival [hazard ratio (HR)=1.540; 95% confidence interval (CI): 1.079–2.199; P=0.017], with this relationship also being preserved in a multivariate analysis (HR =6.892; 95% CI: 1.713–27.727, P=0.007) . GSEA revealed high PCAT6 expression to be linked to differential DNA methylation enrichment, with high PCAT6 levels being associated with changes in base excision repair, cellular senescence, G2/M DNA damage checkpoint, chromatin-modifying enzyme, and gene silencing by RNA activity. The high expression of lncRNA PCAT6 in CRC cell lines was  \ndemonstrated by PCR experiments.  \nConclusions: PCAT6 represents a promising prognostic biomarker of poor ","cbCaidWmXDatqRse","https://ap.wps.com/l/cbCaidWmXDatqRse","pdf",1306863,13,"English","# Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Epidemiology and clinical challenge\n## Treatment overview","[{\"question\":\"How did the study measure PCAT6 and relate it to CRC?\",\"answer\":\"PCAT6 expression in CRC tumors and normal tissues was assessed using TCGA-based analyses with Wilcoxon rank-sum tests and logistic regression. Survival associations were evaluated using Kaplan-Meier curves and Cox regression, with CRC cell line expression supported by qRT-PCR.\"},{\"question\":\"Which clinical features were associated with higher PCAT6 levels?\",\"answer\":\"Higher PCAT6 levels were significantly associated with CRC lymph node metastasis (N stage), distant metastasis (M stage), higher CEA levels, lymphatic invasion, perineural invasion, and more advanced pathologic stage, including stage III/IV versus I/II.\"},{\"question\":\"What survival impact did PCAT6 expression show?\",\"answer\":\"CRC patients with higher PCAT6 expression had poorer survival outcomes (P=0.017). The association remained significant in both univariate and multivariate analyses, indicating PCAT6 as a prognostic indicator.\"}]","LncRNA PCAT6 is a predictor of poor prognosis of colorectal cancer - Research Study Summary | PDF",1790047362,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc7611497b956608ccdf2b33292c129a.webp",983,1287,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68c7ddc6618bab396ed99f14a9e695b7.webp",982,1286,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/461f5547526f87ad5b49d8a68b5ce224.webp",981,1284,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/470bf8a0589e449a9ef1985807ebcff6.webp",980,1283]